company

FARMAKS AS

1369 STABEKK

Return on Equity
22,46 %
Current Ratio
4,59
Debt-to-Equity Ratio
−1,56
Key figures (NOK)2022
Revenue18 000
Net Income−42 000
Total Assets131 000
Total Equity−187 000
Income (NOK)2022
Revenue18 000
Expenditure60 000
Operating Profit−42 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−42 000
Tax0
Net Income−42 000
Balance (NOK)2022
Total Fixed Assets7 000
Total Current Assets124 000
Total Assets131 000
Total Retained Equity−287 000
Total Equity−187 000
Total Long-Term Debt291 000
Total Current Debt27 000
Total Equity and Debt131 000
Cash flow (NOK)2022
Sales Income18 000
Other Income0
Revenue18 000
Cost of Goods Sold0
Salary Costs13 000
Depreciation0
Impairment0
Expenditure60 000
Operating Profit−42 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−42 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures7 000
Total Tangible Assets7 000
Total Fiancial Fixed Assets0
Total Fixed Assets7 000
Stock115 000
Total Investments0
Cash, Bank4 000
Total Current Assets124 000
Total Assets131 000
Total Equity−187 000
Short-Term Group Debt0
Total Long-Term Debt291 000
Creditors0
Unpaid Taxes2 000
Dividends0
Other Current Debt24 000
Total Current Debt27 000
Total Equity and Debt131 000
Financial indicators2022
Return on Equity22,46 %
Debt-to-Equity Ratio−1,56
Operating Profit Margin−233,33 %
Current Ratio4,59
Quick Ratio−1,41
Equity Ratio−1,43
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English